ESR unveils plan for new hybrid imaging society November 23, 2015 -- The European Society of Radiology (ESR) is set to welcome the European Society for Hybrid Medical Imaging under its umbrella, in line with efforts to increase training in nuclear medicine. Dr. Katrine Riklund will preside over the new society, and the official launch will take place at ECR 2016.
Rubidium PET/CT reveals vascular problems in diabetes patients November 16, 2015 -- Danish researchers have found high rates of microvascular disease using PET/CT with a rubidium radiopharmaceutical in diabetes patients without symptoms of heart disease. The disease was exacerbated in the setting of albuminuria, a common condition in these patients, according to a new study in Diabetologia.
Three-pronged glioma therapy shows promise November 5, 2015 -- A combination of x-rays, chemotherapy, and a radiosensitizing drug more than doubled tumor cell death in vitro compared with a radiation-only control, according to Australian research. The combination selectively targets tumor cells and can reduce side effects in patients.
FDG-PET predicts survival in Parkinsonian syndrome October 19, 2015 -- FDG-PET strongly predicts overall survival in patients suspected of having early-stage atypical Parkinsonian syndrome, according to a study in the October Journal of Nuclear Medicine. The modality's findings closely matched clinical diagnosis at one-year follow-up.
MR targeting directs cancer-killing cells October 2, 2015 -- Conventional cancer treatments using chemotherapy drugs can suffer from nonspecificity. New research shows MRI can direct cancer-killing cells to target sites. Not only does this technology target cancer kills, it enables anticancer agents to reach tumor sites that are normally inaccessible.
First choice for neuroendocrine tumors: Ga-68 DOTATATE September 22, 2015 -- PET/CT imaging with radiopharmaceutical gallium-68 (Ga-68) DOTATATE significantly improves whole-body staging of patients with neuroendocrine tumors and should be the modality of choice in these cases, according to German researchers.
Neuroimaging underlines untapped potential of meditation September 17, 2015 -- Imaging studies have confirmed that meditation can create the same physiological changes in the brain as medication for patients with clinical depression. More research needs to be done, but initial evidence suggests that, instead of medicating, people should try meditating.
PET/MRI can be a boon for pediatric cancer patients September 11, 2015 -- Young pediatric patients may benefit from FDG-PET/MRI for staging and clinically evaluating oncologic disorders, given the hybrid modality's superior soft-tissue contrast and significantly lower radiation dose, according to a study published online August 24 in Investigative Radiology.
Lancet: Dementia imaging on cusp of a revolution September 10, 2015 -- Imaging is on the "cusp of a revolution," according to a pan-European group of researchers who have studied the mounting evidence supporting the use of different imaging modalities in both early and established dementia. Their personal view was published online by Lancet Neurology.
PET/MRI matches PET/CT for recurrent pelvic cancer September 8, 2015 -- PET/MRI can provide high diagnostic performance for restaging gynecological cancer patients compared with FDG-PET/CT, with only slightly longer scan time and "markedly reduced" radiation exposure, according to a German study published online in the European Journal of Radiology.